NCT06665776View on ClinicalTrials.gov

HLA-A*02:01 Allele Frequency and the NY-ESO-1 Expression Status in Cancer Patients in Taiwan

RecruitingOBSERVATIONAL
Enrollment

1,200

Participants

Timeline

Start Date

March 14, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Solid Tumor Malignancy
Trial Locations (6)

704

RECRUITING

National Cheng Kung University Hospital, Tainan City

11217

RECRUITING

Taipei Veterans General Hospital, Taipei

407219

RECRUITING

Taichung Veterans General Hospital, Taichung

Unknown

RECRUITING

Chang Gung Memorial Hospital, Chiayi Branch, Chiayi City

RECRUITING

National Taiwan University Hospital, Taipei

RECRUITING

Taipei Medical University Hospital, Taipei

Sponsors

Lead Sponsor

PharmaEssentia
All Listed Sponsors
lead

PharmaEssentia

INDUSTRY